ALDER BIOPHARMACEUTICALS
HQ - Stockholm
Summary
Alder Biopharmaceuticals provides pharmaceutical products and services. The Company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 1.56 B
Avg. Deal Size£ 1.56 B
Investment Criteria
Target Equity CheckUSD 5-20m
Fund CurrencyEUR
Total funds raised$100m-500m
Investment Strategies
Buyout
Growth
Geographic Preferences
Europe
Denmark
Faroe Islands
Finland
Iceland
Norway
Sweden
Industry Preferences
Energy and Power
Renewable Energy
Technology Hardware and Equipment
Commercial Services
Technology
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
